Unlock instant, AI-driven research and patent intelligence for your innovation.

Applications of niclosamide in preparing drugs used for preventing myopia

A technology of niclosamide and myopia, which is applied in the field of application of niclosamide in the preparation of drugs for preventing and treating myopia, and can solve the problems that the application of niclosamide has not been reported.

Active Publication Date: 2015-11-11
XIAMEN UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the application of niclosamide in the treatment of myopia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of niclosamide in preparing drugs used for preventing myopia
  • Applications of niclosamide in preparing drugs used for preventing myopia
  • Applications of niclosamide in preparing drugs used for preventing myopia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1: the impact of niclosamide on the diopter of FDM mice (mouse form deprivation myopia model mice)

[0028] Experimental animals: SPF grade male C57BL / 6J mice (3-4 weeks old) were purchased from Nanjing University-Nanjing Institute of Biomedicine. Slit-lamp microscopy and infrared eccentric photorefractor (EIR) examination ruled out eye diseases, and mice with microphthalmia, corneal opacities, cataracts, and bilateral anisometropia were excluded. All mice were raised under SPF conditions before participating in the experiment, and were given 12 hours of light every day, the light intensity around the cage was 500 lux, the room temperature was controlled at (25±2°C), and adequate food and drinking water were given. After the experiment started, they were raised under normal-grade conditions and fed freely; the room temperature was controlled at 20-25°C, and the light intensity was 250-300lux.

[0029] Grouping: Mice were randomly divided into: control group,...

Embodiment 2

[0034] Embodiment 2: the impact of niclosamide on vitreous cavity depth (VCD) of FDM mice

[0035] Experimental animals: the same as in Example 1.

[0036] Grouping: with embodiment 1.

[0037] Modeling and administration: the same as in Example 1.

[0038] Vitreous cavity depth test method: use optical coherence tomography OCT (wavelength 1310nm, light source bandwidth 60nm, resolution accuracy 10μm) to measure ocular biological parameters (ZhouX, XieJFau-ShenM, ShenMFau-WangJ, et al.Biometricmeasurementofthemouseeyeusingopticalcoherencetomographywithfocalplaneadvancement.) The principle of the optical interferometer is to detect the back reflection or several scattered signals of the incident weak coherent light at different depths of the biological tissue. By scanning, the two-dimensional or three-dimensional structural image of the biological tissue can be obtained, which can be used for non-contact, Non-invasive tomography. OCT can measure various refractive parameters...

Embodiment 3

[0041] Example 3: Effect of Niclosamide on Axial Length (AL) of FDM Mice

[0042] Experimental animals: the same as in Example 1.

[0043] Grouping: with embodiment 1.

[0044] Modeling and administration: the same as in Example 1.

[0045] Measuring method of axial length of the eye: the optical coherence tomography OCT, testing and calculation methods as described in Example 2 are used to measure the axial length of the eye. Axial length was defined from the anterior surface of the cornea to the retinal nerve RGC cell layer.

[0046] Experimental results: As shown in Table 1, before the experiment, there was no significant difference in the axial length (AL) of the left and right eyes of the experimental animals within each group and between each group (P>0.05, paired t test, P>0.05, one-way analysis of variance) .

[0047] as table 2 and image 3 As shown, after 4 weeks of the experiment, the axial length of the deprived eye in the FDM group was increased by 0.048±0.00...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses applications of niclosamide in preparing drugs used for preventing myopia. Niclosamide can be used for preventing and treating myopia via inhibiting myopic refraction deviation, inhibiting myopic vitreous chamber depth increasing, and inhibiting myopic optic axis length increasing; and few influences are caused on aniaometropia development of health eyes. It is confirmed that niclosamide can be taken as a potential drug used for preventing myopia, and possesses certain research prospect.

Description

technical field [0001] The invention relates to the application of niclosamide in the preparation of medicines for preventing and treating myopia. Background technique [0002] Myopia is a common refractive error. Under normal circumstances, the refractive system of the eye and the axial length of the eye cooperate with each other, so that parallel light rays from external objects (generally considered to be from beyond 5m) pass through the refractive system of the eye and focus on the fovea of ​​the retina to form a clear object. Like, its required accuracy reaches 0.1mm. When the eye axis is relatively long, parallel rays of light are imaged in front of the retina, forming myopia. Clinical patients show that they can see nearby objects clearly but cannot see distant objects clearly, so they often need to be corrected by concave lenses. There are more than 500 million myopia patients in the world. Simple myopia brings inconvenience to patients' lives, while high myopia, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/167A61P27/10
Inventor 刘祖国刘真杨文照朱贞贞邱芳芳李炜陈文生
Owner XIAMEN UNIV